| Role |
Name |
Disclosure |
Details |
| Author | Julie R Kenner, MD, PhD, Consultant, Clinical Research, Medical Affairs, VaxGen, Inc; Private Practice, Kenner Dermatology Center | Nothing to disclose | Details | | Coauthor | Peter J Weina, MD, PhD, COL, Director, Division of Experimental Therapeutics, Leishmania Diagnostics Laboratory | Nothing to disclose | Details | | Medical Editor | Abdul-Ghani Kibbi, MD, Chairman and Professor, Department of Dermatology, American University of Beirut Medical Center, Lebanon | none | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory | Nothing to disclose | Details | | CME Editor | Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
|